System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ciro Costagliola is an expert in Ophthalmology at University of Naples Federico II (Italy). As of October 2026, ScienceLeadR ranks Ciro Costagliola in the top 1% of experts worldwide for Cataract, Retinal Diseases and Pilot Projects. Ciro Costagliola has authored 443 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 3 of them ongoing. SLR score: 1,767 (community average: 125). How the SLR is computed.

LeadR Profile

Ciro Costagliola University of Naples Federico II Italy
1 767 ScienceLeadR Reputation 1767

Unlock

Register Login
Network Map

Ophthalmology

Subspecialties: Neurology - Biochemistry - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026
Source: PubMed

University of Naples Federico II

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 443

Citations

Citations: 9 590 1st author: 78 Last author: 180 Unique author: 3

Main journals

Invest Ophthalmol Vis Sci 29
Eur J Ophthalmol 19
J Clin Med 19
Graefes Arch Clin Exp Ophthalmol 17
Exp Eye Res 13

Best Journals

Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Contrast Sensitivity, Quality of Life, and Reading Performance in Glaucoma: A Randomized Crossover Study Comparing Citicoline 500 mg/Homotaurine 50 mg/Nicotinamide 54 mg/Pyrroloquinoline Quinone 5 mg and Citicoline 500 mg.
PMID 42939385 — quality of life, contrast sensitivity, reading, niacinamide, cross-over studies, glaucoma, open-angle, neuroprotection, glaucoma, pqq cofactor, neurodegenerative diseases, cytidine diphosphate choline		Brain Sci20260
Comparative quantitative analysis of choroidal abnormalities in patients with type 1 neurofibromatosis using multimodal retinal imaging.
PMID 42829005 — ophthalmology, neurofibromatosis 1, neurofibromatoses, retinaldehyde		Can J Ophthalmol20260
The Behavior of the External Limiting Membrane and Ellipsoid Zone in Diabetic Macular Edema: A Population AI-Assisted Optical Coherence Tomography Study.
PMID 42765790 — eye, ophthalmology, tomography, biomarkers, macular edema, visual acuity, tomography, optical coherence, artificial intelligence, retinaldehyde, membranes, edema		Invest Ophthalmol Vis Sci20260
IL-17 at the eye - joint interface in psoriatic disease: mechanisms, clinical correlates, and therapeutic implications.
PMID 42573121 — scleritis, immune system diseases, therapeutics, biological therapy, dry eye syndromes, interleukin-17, uveitis		Expert Rev Clin Immunol20260
Rethinking intraocular pressure: What does tonometry actually measure?
PMID 42562869 — ophthalmology, intraocular pressure		Eye (Lond)20260

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Director: 1

By phase:

N/A 16
Phase 3 2
Phase 2 1
Phase 4 1

By status:

Completed 14
Unknown 3
Active not recruiting 1
Not yet recruiting 1
Recruiting 1

By type:

Interventional 10
Observational 10

By Monocentric/Multicentric:

monocentric 15
multicentric2to4 2
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to test whether BI 764524 helps people with an eye condition called diabetic retinopathy
2023-508891-12-00 — eye, safety, diabetic retinopathy, pharmacokinetics		Phase 2Active not recruiting2024
Real world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP
NCT07206628 — hypertension, treatment adherence and compliance, glaucoma, ocular hypertension, therapeutics		N/ARecruiting2025
LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE RELATED MACULAR DEGENERATION (AMD)
NCT06465342 — macular degeneration, lutein, iontophoresis		N/ANot yet recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS